Member Info for Traxpern

Excuse me?

Nasdaq will see to that

Moving up

Https://www.kidneyfund.org/article/study-results-show-promising-effects-semaglutide-people-diabetic-kidney-disease

Complimentary diagnostic tool will be pivotal for nova and renalytix have the ip

Https://ideas.mountsinai.org/impact/renalytix

Https://www.partnerbase.com/mount-sinai/novo-nordisk

Mount Sinai holders in renalytix

Https://ideas.mountsinai.org/partners

Multi bagger imo

Https://m.investing.com/news/company-news/renalytix-partners-with-steno-for-kidney-care-in-europe-93CH-3515580?ampMode=1

Https://novonordiskfonden.dk/en/grant/steno-north-american-fellowships/

Https://investors.renalytix.com/news-releases/news-release-details/renalytixai-and-joslin-diabetes-center-build-proprietary-kidney

These patents are a huge asset for renalytix

Https://renalytix.com/us-patent-office-allows-patent-claims-for-intellectual-property-exclusively-licensed-to-renalytix/

Good luck

Let’s hope for a great day

Https://www.novonordisk.com/news-and-media/news-and-ir-materials/news-details.html?id=167028

Complimentary to nova nordisk treatments

This has to be the company that has made an approach

Let’s hope they buy us out.

I’m thinking for $200 million plus

Disclosure

A.Sharma: None. B.Burguera: Research Support; Novo Nordisk. M.Kattan: Consultant; Renalytix, Verici, Research Support; Novo Nordisk

M Kattan is a consultant for renalytix and nordisk

See the disclosure at the bottom of that report

In link below

Https://diabetesjournals.org/diabetes/article/72/Supplement_1/12-LB/150261/12-LB-Clinical-Impact-of-Risk-Profiling-with

Yes it is and hopefully they buy us out

Fits perfectly with their diabetes meds

Https://www.ucl.ac.uk/consultants/ucl-novo-nordisk-and-steno-diabetes-center-partner-take-action-against-urban-diabetes

Novo nordisk/steno

See how it goes after hours

Perhaps a solid offer is about to be accepted. Seems leaky.

£2 a hate please sir